Novavax Inc. (NASDAQ: NVAX) said on Tuesday that it inked an agreement with the U.S. government that makes it liable to deliver 100 million doses of its candidate vaccine for COVID-19 in the U.S. by J
The company said the first doses could be ready as early as the end of the summer.
Investors again were turning their attention to rising coronavirus cases across the country.
European markets are expected to open slightly lower Tuesday as concerns over the threat to economic recovery of new coronavirus cases in the U.S. temper Monday's rally.
Stocks - Novavax, Sunrun, Tesla Rise Premarket; United Airlines Drops
Becton Dickinson (NYSE: BDX) dijo el lunes que recibió la autorización de uso de emergencia (EUA) de la Administración de Alimentos y Drogas de EE.UU. (FDA) para su prueba de antígenos COVID-19 qu
Becton Dickinson (NYSE: BDX) ha detto lunedì di aver ricevuto l’autorizzazione all’uso d’emergenza (EUA) dalla U.S. Food and Drug Administration (FDA) per il suo test dell’antigene COVID-19 c
Regeneron said it was starting three late-stage trials of a drug designed to treat and prevent Covid-19.

New York City Enters Third Phase of Reopening

01:47pm, Monday, 06'th Jul 2020
Here’s what you need to know about the impact of Covid-19 to navigate the markets today.
Becton Dickinson (NYSE: BDX) said on Monday that it received emergency use authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 antigen test that takes up to 15 minute
Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the completion of patient dosing in Cohort 4 of O

PreMarket Prep Stock Of The Day: Regeneron

12:00am, Monday, 06'th Jul 2020
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news...
Parametric Portfolio Associates LLC raised its holdings in shares of Editas Medicine Inc (NASDAQ:EDIT) by 19.5% during the first quarter, according to its most recent disclosure with the Securities an
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Director Michael S. Brown sold 3,613 shares of the firm’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $607.
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adverum Biotechnologies
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE